First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
As part of our annual drug trends series, we’re taking a deeper dive into some of the therapeutic classes showing the biggest increases among the t
Claims organizations continue to build and enhance their global digitization strategies, especially in the midst of the COVID-19 pandemic.
As the COVID-19 pandemic continues, companies around the world are still facing many challenges, including how to remain operational in a remote en
When a claimant doesn’t have the right technology for a telemedicine appointment, claim and treatment delays ensue.